Anchor Investment Management LLC Cuts Holdings in Humana Inc. (NYSE:HUM)

Anchor Investment Management LLC decreased its stake in shares of Humana Inc. (NYSE:HUM) by 2.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,492 shares of the insurance provider’s stock after selling 65 shares during the quarter. Anchor Investment Management LLC’s holdings in Humana were worth $789,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Creative Financial Designs Inc. ADV increased its holdings in shares of Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 61 shares during the last quarter. CarsonAllaria Wealth Management Ltd. boosted its position in shares of Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares during the period. Atwood & Palmer Inc. acquired a new stake in shares of Humana in the 3rd quarter valued at about $29,000. Ashton Thomas Securities LLC purchased a new position in shares of Humana in the 3rd quarter valued at approximately $31,000. Finally, Your Advocates Ltd. LLP grew its stake in shares of Humana by 81.8% in the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Trading Down 1.9 %

Shares of HUM opened at $272.78 on Friday. The stock has a 50-day moving average price of $272.83 and a 200 day moving average price of $325.59. Humana Inc. has a one year low of $213.31 and a one year high of $488.89. The company has a market capitalization of $32.85 billion, a P/E ratio of 24.16, a P/E/G ratio of 2.15 and a beta of 0.53. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. The firm had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Sell-side analysts forecast that Humana Inc. will post 16.14 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.30%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the company. Royal Bank of Canada decreased their price target on Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Piper Sandler cut Humana from an “overweight” rating to a “neutral” rating and reduced their price objective for the stock from $392.00 to $274.00 in a report on Thursday, October 3rd. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and boosted their price target for the stock from $247.00 to $308.00 in a report on Wednesday, November 6th. Barclays boosted their price target on Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a report on Thursday, October 31st. Finally, Leerink Partners lowered Humana from an “outperform” rating to a “market perform” rating and dropped their target price for the company from $400.00 to $250.00 in a research note on Wednesday, October 2nd. Twenty analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $304.15.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.